Work

Abstract S5-04: Primary results of ROSE/TRIO-12, a randomized placebo controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs13-s5-04

Authors: JR Mackey, M Ramos-Vazquez, O Lipatov, N McCarthy, D Kraznozhon, V Semiglazov, A Manikhas, K Gelmon, G Konecny, M Webster, R Hegg, S Verma, V Gorbounova, D Abi Gerges, F Thireau, H Fung, L Simms, M Buyse, A Ibrahim, M Martin

Institutions: University of California, Los Angeles, Centro Oncológico de Galicia, Institute of Oncology NN Petrov, City Clinical Oncology Center, Cancer Research Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2005692436

Cites:

Cited by: 10

Related to: 10